Lupin Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets. ".
Lupin Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets. ".